IQVIA Logo

Insight

Understanding Gastrointestinal Toxicity Risk Through Human Relevant Intestinal Models

Translational safety insights help differentiate risk and support more informed development decisions.
Understanding Gastrointestinal Toxicity Risk Through Human Relevant Intestinal Models
Home / Insights / Understanding Gastrointestinal Toxicity Risk Through Human Relevant Intestinal Models

Gastrointestinal toxicity remains a major challenge for targeted therapies, often impacting dose optimization and patient tolerability. See how iPSC-derived intestinal organoids, high-content imaging, and PBPK modeling were used to differentiate GI toxicity risk across EGFR inhibitors and generate translational insights to support safer development decisions.

 


Download Document